Eterna Therapeutics is focused on exploring the role that the human immune system can have in treating patients with cancer and immunologic diseases, both as a single agent and in combination with other therapies.

Biotechnology

Pharmaceutical

Eterna Therapeutics

Ron Guido

Howard J. Federoff

The leadership team at Brooklyn ImmunoTherapeutics has a wealth of experience in the healthcare and neuroscience industries. They have advised and led at companies such as Aspen Neuroscience, and have also been Vice Chancellor for Health Affairs and CEO UC Irvine Health System at University of California, Irvine. Furthermore, the team is highly educated, with degrees from esteemed schools such as Albert Einstein College of Medicine.

Leadership Team

About

Team members

Other teams at Eterna Therapeutics

Board of Directors

CEO and Executive Team